Gateshead Health NHS Foundation Trust

Northern, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 175 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 164 94.0% 86.9%
Treatment planning
– HGD plan discussed at MDT 158 90.1% 87.9%
– Treatment plan for active treatment 122 69.6% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 104 59.5% 73.8%
– Surveillance 26 14.9% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 112 20528
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
20 15.5% 13.3%
– Patients with referral source reported as unknown 0 0.0% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 108 96.4% 86.9%
Treatment planning
– Patients having a plan for curative treatment 36 32.1% 38.5%
– Patients having a plan for non-curative treatment 76 67.9% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 31 40.8% 48.2%

Download this data as a PDF